Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
178 studies found for:    Open Studies | "Edema"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Edema"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide
Condition: CYSTOID MACULAR EDEMA
Interventions: Drug: Ranibizumab,;   Drug: Triamcinolone acetonide
2 Not yet recruiting Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME)
Condition: Macular Edema
Intervention: Biological: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
3 Recruiting A Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macular Oedema
Condition: Macular Edema
Interventions: Drug: Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321);   Drug: Anti-VEGF therapies including: Eylea Aflibercept, VEGF Trap-Eye, BAY86-5321) and Ophthalmologicals / Antineovascularisation agents (S01LA05)
4 Not yet recruiting Does NMES Help Relieve Lower Limb Oedema and Improve Joint Mobility and Skin Tissue Oxygenation Levels?
Condition: Oedema
Intervention: Device: Custom-built, two-channel stimulator
5 Not yet recruiting Effect of 80-mg Atorvastatin on Myocardial Edema
Condition: Myocardial Edema
Interventions: Drug: Atorvastatin 80mg;   Drug: Atorvastatin 10mg
6 Not yet recruiting Near Infrared Photobiomodulation Treatment for Diabetic Macular Oedema
Condition: Diabetic Macular Oedema
Intervention: Device: Ellex Integre NIR laser
7 Recruiting Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema
Condition: Diabetic Macular Edema
Intervention: Drug: aflibercept
8 Recruiting Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide
Condition: Diabetic Macular Edema
Intervention: Drug: Triamcinolone Acetonide
9 Recruiting Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Drug: Ozurdex;   Drug: Lucentis
10 Not yet recruiting Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen of Aflibercept (EYLEA) as a Second Line Treatment for Diabetic Macular Edema
Condition: Diabetic Macular Edema (DME)
Intervention: Drug: Aflibercept
11 Recruiting Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema
Condition: Diabetic Macular Edema
Intervention: Drug: Ranibizumab
12 Recruiting Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME)
Condition: Diabetic Macular Edema
Interventions: Drug: Ranibizumab;   Drug: Bevacizumab
13 Not yet recruiting Unilateral Pulmonary Edema After Minimal-invasive Mitral Valve Surgery
Condition: Pulmonary Edema
Intervention:
14 Not yet recruiting Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Patients With Persistent Diabetic Macular Edema Following Treatment With Ranibizumab: An Interventional Prospective Study
Condition: Diabetic Macular Edema
Intervention: Biological: aflibercept
15 Recruiting Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema
Condition: Inflammatory Macular Edema
Interventions: Drug: Dexamethasone;   Drug: Triamcinolone
16 Not yet recruiting Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Drug: bevacizumab;   Device: PASCAL Endpoint Management (EpM) laser treatment
17 Recruiting Study of Using the Hyper-CL™ Lens (Hyper Osmotic Contact Lens) in Subjects Suffering From Corneal Edema
Condition: CORNEAL EDEMA
Interventions: Device: Hyper-CL™ lens;   Device: Regular soft contact lens;   Drug: Salt solution
18 Recruiting Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema
Condition: Macular Edema
Interventions: Drug: BI 1026706;   Drug: Placebo
19 Not yet recruiting AOI-Chronic Oedema Study
Condition: Lower Limb Chronic Oedema
Intervention: Other: Patients will undergo a lower limb MRI and blood tests
20 Recruiting Identifying Patients With Unrecognized Treatable Diabetic Macular Edema
Condition: Diabetic Macular Edema
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.